Media Room
Contact Us
Français
Discover
Technology
Dermatology
Medical
Investor Relations
Pipeline
A strong yielding, multi-applications, late stage product pipeline
Progress
Potential Market
Preclinical Data
Proof of Concept
Registration Trial
Registration
Commercialized
SKR-1
Skin Rejuvenation
$5B
AC-1
Acne Vulgaris
$3B
WH-1
Chronic Wounds
$3B
PERIO-1
Periodontitis
$6B